Boots' potential return to the London Stock Exchange is gaining momentum, with market watchers suggesting that an Initial Public Offering (IPO) could now be more likely following Australian pharmacy giant Sigma Healthcare's withdrawal from discussions over a £7.5bn takeover bid. This development marks a significant shift in the fortunes of the British pharmacy chain, which has been valued at up to £7bn and has reportedly engaged advisers since April to prepare for a London listing.
A Boots IPO would be a major coup for the UK's capital markets, injecting much-needed vitality into the domestic market amidst a period of reduced new listings. The company's recent performance under private ownership is encouraging, with pre-tax profits reaching £337m in the year to August last year, up 25% from the previous year. However, investors would need to be convinced that Boots can justify an ambitious valuation within a highly competitive retail landscape.
Russ Mould, investment director at AJ Bell, noted that Sigma's departure from sale talks has increased the likelihood of a Boots IPO. He pointed out that the subsequent rise in Sigma's share price suggests investors view the potential acquisition as a "bullet dodged," rather than a reflection on Boots itself. Mould emphasised that a Boots IPO would provide a much-needed boost for the London market, particularly given the challenges posed by high-profile companies opting to list in New York or being acquired by private buyers.
Nicholas Found, retail analyst, cautioned that while Sigma's exit has cleared the way for a potential IPO, it does not automatically make the process straightforward. Boots would need to demonstrate its ability to justify an ambitious valuation, particularly given its complex ownership history and the inherent risks of a large international takeover.
Boots' path to an IPO will be closely watched by investors, who will seek clarity on how the company plans to expand beyond its traditional retail pharmacy model. Analysts point out that while its time in private hands hasn't been disastrous, parts of its store estate may require investment, and its digital strategy could be sharpened. The potential for Boots to tap into the booming beauty and wellness sectors is also a key consideration for investors.